1-5 of 5
Dongmei Ji
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial

Xiaomin Ou, Ruiping Zhai, Wenjun Wei, Jiaying Chen, Dan Ou, Tian Liao, Tingting Xu, Yongxue Zhu, Yulong Wang, Shenglin Huang, Rongliang Shi, Bin Wu, Tongzhen Chen, Yuan Li, Zhongyi Yang, Changming Zhou, Yuan Liu, Ziting Jiang, Min Zeng, Xin Liu, Dongmei Ji, Hongmei Ying, Zhen Zhang, Chaosu Hu, Xueguan Lu, Qinghai Ji, Xiayun He, Yu Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (2): 344–355.
https://doi.org/10.1158/1078-0432.CCR-23-2398
Published: 17 January 2024
View article titled, Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Open the PDF for Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer

Jian Zhang, Dongmei Ji, Weina Shen, Qin Xiao, Yajia Gu, Joyce O'Shaughnessy, Xichun Hu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (19): 4212–4221.
https://doi.org/10.1158/1078-0432.CCR-22-0456
Published: 03 October 2022
View article titled, Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer
Open the PDF for Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study

Jian Zhang, Dongmei Ji, Li Cai, Herui Yao, Min Yan, Xiaojia Wang, Weina Shen, Yiqun Du, Hui Pang, Xiuping Lai, Huiai Zeng, Jian Huang, Yan Sun, Xinxin Peng, Junfang Xu, Jing Yang, Fei Yang, Ting Xu, Xichun Hu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 618–628.
https://doi.org/10.1158/1078-0432.CCR-21-2827
Published: 15 February 2022
View article titled, First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study
Open the PDF for First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study in another window
Includes: Supplementary data
Journal Articles

The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy

Chenchen Wang, Weijian Guo, Min Zhou, Xiaodong Zhu, Dongmei Ji, Wenhua Li, Xin Liu, Zhonghua Tao, Xiaowei Zhang, Yingjian Zhang, Jin Li
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (7): 1603–1610.
https://doi.org/10.1158/1078-0432.CCR-14-3235
Published: 31 March 2016
View article titled, The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy
Open the PDF for The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Functional Genetic Approach Identifies MET, HER3, IGF1R, INSR Pathways as Determinants of Lapatinib Unresponsiveness in HER2-Positive Gastric Cancer

Zhe Zhang, Jiping Wang, Dongmei Ji, Chenchen Wang, Rujiao Liu, Zheng Wu, Lian Liu, Dan Zhu, Jinjia Chang, Ruixuan Geng, Lei Xiong, Qiangyi Fang, Jin Li
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (17): 4559–4573.
https://doi.org/10.1158/1078-0432.CCR-13-3396
Published: 01 September 2014
View article titled, Functional Genetic Approach Identifies MET, HER3, IGF1R, INSR Pathways as Determinants of Lapatinib Unresponsiveness in HER2-Positive Gastric Cancer
Open the PDF for Functional Genetic Approach Identifies MET, HER3, IGF1R, INSR Pathways as Determinants of Lapatinib Unresponsiveness in HER2-Positive Gastric Cancer in another window
Includes: Supplementary data